day 1 agenda

Scientific Program
  Hall Name: Sant Boi + Cornella
Day -1 (Sept 20, 2022)
Karine Breckpot, Vrije Universiteit Brussel, Belgium
08:00 - 09:00 Registrations
09:00 - 09:10 Opening Ceremony & Moderator Speech
09:10- 09:40 Title: Annulling immune evasion in breast cancer by PI3K inhibitors or H1-antihistamines
Yu Dihua,The University of Texas MD Anderson Cancer Center, USA
09:40- 10:10 Title: CRISPR interference and activation of the microRNA-3662-HBP1 axis control triple-negative breast cancer progression
Runa LIU, University of Alabama, USA
10:10- 10:40 Title: Immunological targeting of the oncogene tMUC1 leads to significant anti-tumor effects in breast cancer
Pinku Mukherjee, UNC Charlotte, USA
10:40 - 10:55 Group Photo & Refreshment Break @Foyer
Morning Session: Breast Cancer Screening & Diagnosis
Session Chairs:
Runa LIU, University of Alabama, USA
Alberto Izzotti, University of Genoa, Italy
10:55 - 11:15 Title: Quantitative Fluorescence Polarization Optical Cytology of Breast Cancer
Anna N Yaroslavsky, University of Massachusetts, USA
11:15 - 11:35 Title: Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening
Helena Teng, McMaster University, Canada
11:35-11:55 Title: In vitro and in vivo estrogenic anti-estrogenic activity of selected triphenylethylene derivatives – chemistry meets biology
Jannette Wober, Technische Universitat Dresden, Germany
11:55-12:15 Title: HER2-Low Breast Cancers: New opportunities and Challenges
Huina Zhang, University of Rochester Medical Center, USA
12:15-12:35 Title: Breast Cancer Awareness Among Afghan Refugee Women
Mutlay Sayan, Harvard University, USA
12:35-12:55 Title: Novel pathogenic variants in PALB2 and BARD1 genes that associated with ER+ breast cancer in Saudi Population 
Yousef MohammedRabaa Hawsawi, King Faisal Specialist Hospital and Research Centre, Saudi arabia
12:55-13:55 Lunch Break @ Restaurant
Session: Breast Caner Research & Treatment
Session Chairs:
Huina Zhang, University of Rochester Medical Center, USA
Chen Guan, Medical College of Wisconsin, USA
13:55-14:15 Title: Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
Karine Breckpot, Vrije Universiteit Brussel, Belgium
14:15 - 14:35 Title: p38g integrates metabolic and immune signaling in breast tumorigenesis
Chen Guan & Xiao-Mei Qi, Medical College of Wisconsin, USA
14:35 - 14:55 Title: Prevention of breast cancer relapses by oxidizing drugs and microRNA modulation
Alberto Izzotti, University of Genoa, Italy
14:55-15:15 Title: Antibiotic prophylaxis in breast surgery: a meta-analysis to identify the optimal strategy to reduce infection rates in breast surgery
Bader Nawaf Alali, Mubarak Al Kabeer Hospital, Ministry of Health, kuwait
15:15-15:35 Title: New therapeutic approaches in the treatment of triple-negative breast cancer
Krisztina Kovacs, University of Pécs, Hungary
15:35-15:55 Title: Cancer biomarker in white blood cells – An enlighten technology for cancer screening
Charoenchai P., Chulalongkorn University, Thailand
15:55-16:05 Refreshment Break
16:05-16:25 Title: Metastatic Breast Cancer Presenting as Pulmonary Nodules and Right Axillary Lymph Node in a Male with Chronic Lymphocytic Leukemia
Jose Maria Acostamadiedo, University of Vermont, USA
16:25-16:45 Title: Achillea fragrantissima (Forssk.) Sch.Bip flower dichloromethane extract exerts anti-proliferative and pro-apoptotic properties in human triple-negative breast cancer (MDA-MB-231) cells In vitro and in silico
Zeyad Ibrahim Alehaideb, King Abdullah International Medical Research Centre, Saudi Arabia
16:45- 16:55 - Refreshment Break
Virtual Session Through ZOOM
Time Zone: CEST - Barcelona Time (16:55 - 18:55)
16:55-17:15 Title:A bioinformatics analysis to investigate long non-coding RNAs mediated gene regulation in human breast invasive carcinoma
Giulia Fiscon, Sapienza University of Rome, Italy
Federica Conte, IASI-CNR of Rome, Italy
17:35-17:55 Title: Hormonally-dependent gene expression involving the Stat5a/HDAC6/HMGN2 complex undergoes dynamic regulation and is exploitable in ER+ breast cancer
Charles V. Clevenger,  Virginia Commonwealth University, USA
17:55-18:15 Title: Mutant ESR1 Receptors Cooperate with the Androgen receptor to drive metastatic progression
Suzanne A. W. Fuqua, Baylor College of Medicine, USA
18:15-18:35 Title: Diagnostic Utility of TRPS1 Immunohistochemistry in Primary and Metastatic Breast Carcinoma with Special Emphasis on Spindle Cell Neoplasms of the Breast
Silvat Sheikh-Fayyaz, Donald and Barbara Zucker School of Medicine, USA
18:35-18:55 Title: Development of a TCR-Like Antibody and Chimeric Antigen Receptor Against NY-ESO-1/HLA-A2 for Cancer Immunotherapy
Rongfu Wang, University of Southern California, USA
  Day 1 Concludes

day 2 agenda

Day-2 (Sep-21, 2022)
Virtual Session Through ZOOM
Time Zone: CEST - Barcelona Time (07:40-18:00)
08:00-08:20 Title: Gene dosage analysis on the single-cell transcriptomes linking cotranslational protein targeting to metastatic triple-negative breast cancer
Min Zhao, University of the Sunshine Coast, Australia
08:20-08:40 Title: Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in patients with breast cancer: Clinical advances and controversies
Junyuan Lv, The Affiliated Hospital of Zunyi Medical University, China
08:40-09:00 Title: Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
Qiang He, Chengdu Second People’s Hospital, China
09:00-9:20 Title: Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer:A Single-Institutional Retrospective Analysis from China
Shuang-long Cai, Provincial Clinical Medical College of Fujian Medical University, China
09:20-09:40 Title: Minimal Invasive Complete Duct Excision With Ultrasound-Guided Vacuum-Assisted Breast Biopsy: A Novel Technique For Pathological Nipple Discharge
Yinguang GAO, Capital Medical University, China
09:40-10:00 Title: A cooperation of CCR7 and CXCR4 ligand chemokines regulate breast cancer cell invasion and migration toward lymphatic vessels
Haruko Hayasaka, Kindai University, Japan
10:00-10:20 Title: Spatially-resolved laser-activated cell sorting for breast cancer biomarker discovery
Amos Chungwon Lee, Seoul National University, South korea
10:20-10:40 Title: Analysis of a Breast Cancer Mathematical Model. Optimal Protocol for HER2+  BC
OPhir Nave, Jerusalem College of Technology, Israel
10:40-11:00 Title: A review of the endocrine resistance in hormone-positive breast cancer
Tsai-Ju Chien, National Yang-Ming Chiao Tung University, Taiwan
11:00-11:20 Title: Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
Ioannis Karampinis, University of Mainz, Germany
11:20-11:40 Title: Impact of doxorubicin on cell-substrate topology
Herbert Schneckenburger, Aalen University, Germany
11:40-12:00 Title: Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein
Joanna Kopecka, University of Turin, Italy 
12:00-12:20 Title: SWIM: a network-based approach for human diseases
Paola Paci, Sapienza University of Rome, Italy
12:20-12:40 Title: Breast cancer stem cell antigens as targets for immunotherapy and targeted therapies
Laura Conti, University of Turin, Italy 
12:40-13:00 Title: Preimplantation Genetic Testing for breast cancer
Oladapo Ashiru, Medical Art Center Clinic, Nigeria
13:00-13:20 Title: Transcription and translation regulation work together during a luminal to basal transition of breast cancer cells 
Tamara Fernández-Calero, Universidad Católica del Uruguay/ Institut Pasteur de Montevideo, Uruguay
13:20-13:40 Title: Targeting ectopic Hsp90 with PET enabled Hsp90 inhibitors to noninvasively detect and treat metastatic breast cancer
Timothy Haystead, Duke University, USA
13:40-14:00 Title: Impact of smoking cessation on survival of breast cancer patients
Kareem Seoudy, University of Virginia, USA
14:00-14:20 Title: Tumor-Driving EGFR/K-RAS/SIAH Pathway Activation for Risk Stratifying Patients, Quantifying Therapy Efficacy, Detecting Cancer Disparity, Forecasting Tumor Relapse, and Predicting Patient Survival in Triple-Negative Breast Cancer
Amy H. Tang , Eastern Virginia Medical School, USA
14:20-14:40 Title: Identification of distinct immune landscapes using multiplex immunofluorescence in paraffin tumor tissues
Edwin R. Parra, The University of Texas, USA
14:40-15:00 Title: Achieving highly efficient breast ultrasound tumor classification with deep convolutional neural networks
Pinki Roy, National Institute of Technology Silchar, India
15:00-15:20 Title: Hybrid metabolic phenotype and mitochondria-nuclear crosstalk can regulate breast cancer progression
Benny Kaipparettu, Baylor College Of Medicine, USA
15:20-15:40 Title: .Impact of using median vs. mean in calculating ERBB2 FISH results in breast cancer
Jianli Dong, University of Texas Medical Branch, USA
15:40-16:00 Title: Steroid receptor co-activator complexes regulate breast cancer stem cell pathways to drive therapy resistant ER+ breast cancer
Julie Hanson Ostrander, University of Minnesota, USA
16:00-16:20 Title: Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK–LKB1 Signaling Axis
Richard G Pestell, Baruch S Blumberg Institute, USA
16:20-16:40 Title: Metabolic profiling and tracking phenotypic changes in mitochondria in cancer cells with Mitometer and the phasor approach to FLIM
Michelle Digman, University of California Irvine, USA
16:40-17:00 Title: Src kinase/ CUB-domain containing protein 1/ protein kinase C delta pathway is active in a subset of triple-negative breast cancers and can be targeted
Olga Razorenova, University of California, USA
17:00-17:20 Title: 3D Culture Modeling of Paracrine Interactions between Triple Negative Breast Cancer Cells and Tumor Microenvironment: Lymphatic Networks and Stromal Fibroblasts
Ji, Kyungmin, Wayne State University, USA
17:20-17:40 Title: Evaluating the efficacy of a novel class of Jak3-directed chemitheraputic drugs in Triple negative breast cancer metastasis
Jayshree Mishra, Texas A&M University, USA
17:40-18:00 Title: JWH-133 (cannabinoid receptor 2 agonist) but not ACEA (cannabinoid receptor 1 agonist) increases ectopic ovarian tumor growth in immunocompromised SCID female mice
Isabel Castro-Piedras, Texas Tech University Health Sciences Center, USA
18:00-18:20 Title: Subcutaneous quadrantectomy is a safe procedure in management of early-stage breast cancer
Francesca Cardella, Università degli studi della Campania Luigi Vanvitelli, USA
18:00-18:20 Closing Ceremony & Refreshment Break
If any one interested to attend the conference or to book your speaker slot, please send an email to
Conference Hotel: 
Hotel FrontAir Congress Barcelona,
Carrer de les Alberedes, 16, 08830
Sant Boi de Llobregat,
Barcelona, Spain